Trastuzumab-Doxorubicin Conjugate Provides Enhanced Anti-Cancer Potency and Reduced Cardiotoxicity Journal of Cancer Therapy, Vol.4 No.1
Zenix SEC-300N/AADCN/A
2012
Zenix SEC-300
N/A
SEC
Protein
N/A
Accurate retention time determination of co-eluting proteins in analytical chromatography by means of spectral data Biotechnology and Bioengineering, Volume 110, Issue 3, pages 683-693,
Zenix SEC-300N/AProteinN/A
2011
Zenix SEC-300
N/A
SEC
Antibody
N/A
Antibody solubility behavior in monovalent salt solutions reveals specific anion effects at low ionic strength Journal of Pharmaceutical Sciences, Volume 101, Issue 3, pages 965-977
Zenix SEC-300N/AAntibodyN/A
2012
Zenix SEC-300
N/A
SEC
Antibody
N/A
Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system mAbs, Volume 4, Issue 2, pages 217-225
Zenix SEC-300N/AAntibodyN/A
2012
Zenix SEC-300
N/A
SEC
Protein
N/A
Rapid quantification of protein–polyethylene glycol conjugates by multivariate evaluation of chromatographic data Journal of Chromatography A, Volume 1257, Pages 41-47
Zenix SEC-300N/AProteinN/A
2013
SRT SEC-300
N/A
SEC
Membrane Protein
N/A
The rhodopsin-transducin complex houses two distinct rhodopsin molecules Journal of Structural Biology, Volume 182, Issue 2, Pages 164-172
SRT SEC-300N/AMembrane ProteinN/A
2013
SRT SEC-300
N/A
SEC
Fc Fusion Protein
N/A
Characterization of Fc-fusion protein aggregates derived from extracellular domain disulfide bond rearrangements Journal of Pharmaceutical Sciences, Volume 102, Issue 2, pages 441-453
SRT SEC-300N/AFc Fusion ProteinN/A
2013
SRT SEC-300
N/A
SEC
Membrane Protein
N/A
Steroid-based facial amphiphiles for stabilization and crystallization of membrane proteins PNAS, vol. 110 no. 13
SRT SEC-300N/AMembrane ProteinN/A
2013
Zenix SEC-300
N/A
SEC
Bispecific Antibody
N/A
Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity MAbs, 5(6), 872-81
Zenix SEC-300N/ABispecific AntibodyN/A
2013
Zenix SEC-300
N/A
SEC
PEG/PEGylated Protein
N/A
Optimization of random PEGylation reactions by means of high throughput screening Biotechnology and Bioengineering, Volume 111, Issue 1, pages 104-114
